» Articles » PMID: 12718893

Structural Basis for Bile Acid Binding and Activation of the Nuclear Receptor FXR

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2003 Apr 30
PMID 12718893
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

The nuclear receptor FXR is the sensor of physiological levels of enterohepatic bile acids, the end products of cholesterol catabolism. Here we report crystal structures of the FXR ligand binding domain in complex with coactivator peptide and two different bile acids. An unusual A/B ring juncture, a feature associated with bile acids and no other steroids, provides ligand discrimination and triggers a pi-cation switch that activates FXR. Helix 12, the activation function 2 of the receptor, adopts the agonist conformation and stabilizes coactivator peptide binding. FXR is able to interact simultaneously with two coactivator motifs, providing a mechanism for enhanced binding of coactivators through intermolecular contacts between their LXXLL sequences. These FXR complexes provide direct insights into the design of therapeutic bile acids for treatment of hyperlipidemia and cholestasis.

Citing Articles

Structural basis for the asymmetric binding of coactivator SRC1 to FXR-RXRα and allosteric communication within the complex.

Sheng Y, Guo Y, Zhao B, Sun M, Dong Y, Yin Y Commun Biol. 2025; 8(1):425.

PMID: 40082595 PMC: 11906777. DOI: 10.1038/s42003-025-07854-x.


Simulations Reveal Unique Roles for the FXR Hinge in the FXR-RXR Nuclear Receptor Heterodimer.

Yu T, Biswas A, Dube N, Okafor C ACS Bio Med Chem Au. 2025; 5(1):194-203.

PMID: 39990948 PMC: 11843329. DOI: 10.1021/acsbiomedchemau.4c00105.


Hepatoprotective Effects of Cilnidipine in Cholestatic Liver Disease: Role of FXR and NRF2 Signalling.

Mohammed T, Zalzala M J Exp Pharmacol. 2025; 17:93-105.

PMID: 39989470 PMC: 11844200. DOI: 10.2147/JEP.S504511.


Enhanced dynamic coupling in a nuclear receptor underlies ligand activity.

Yu T, Villalona P, Khan S, Mikeasky N, Meinert E, Magafas J J Biol Chem. 2024; 301(2):108081.

PMID: 39675705 PMC: 11783427. DOI: 10.1016/j.jbc.2024.108081.


SLC10A5 deficiency causes hypercholanemia.

Xu Y, Qian Y, Yu Y, Zhan X, Jin P, Hong J Hepatology. 2024; 81(2):408-422.

PMID: 38986003 PMC: 11737122. DOI: 10.1097/HEP.0000000000000994.